drugset / Trial / NCT01063881

The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy

NCT01063881

Phase 3 Completed 285 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to measure the efficacy of flexible dosing of dapoxetine in a setting similar to routine clinical practice.

Timeline

Start
2010-05-22
Primary completion
2011-06-14
Completion
2011-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapoxetine Small molecule 30 mg
Subject Dapoxetine Small molecule 60 mg